These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
568 related articles for article (PubMed ID: 9259590)
21. Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation. Tsukada N; Kobata T; Aizawa Y; Yagita H; Okumura K Blood; 1999 Apr; 93(8):2738-47. PubMed ID: 10194454 [TBL] [Abstract][Full Text] [Related]
22. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, Fas-Fas ligand-independent pathway. Zhang ZX; Ma Y; Wang H; Arp J; Jiang J; Huang X; He KM; Garcia B; Madrenas J; Zhong R J Immunol; 2006 Nov; 177(10):6920-9. PubMed ID: 17082607 [TBL] [Abstract][Full Text] [Related]
23. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. Johnson BJ; Costelloe EO; Fitzpatrick DR; Haanen JB; Schumacher TN; Brown LE; Kelso A Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2657-62. PubMed ID: 12601154 [TBL] [Abstract][Full Text] [Related]
24. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. Braun MY; Lowin B; French L; Acha-Orbea H; Tschopp J J Exp Med; 1996 Feb; 183(2):657-61. PubMed ID: 8627178 [TBL] [Abstract][Full Text] [Related]
25. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand. Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053 [TBL] [Abstract][Full Text] [Related]
26. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L). Winter H; Hu HM; Urba WJ; Fox BA J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388 [TBL] [Abstract][Full Text] [Related]
27. IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease. Ramirez-Montagut T; Chow A; Kochman AA; Smith OM; Suh D; Sindhi H; Lu S; Borsotti C; Grubin J; Patel N; Terwey TH; Kim TD; Heller G; Murphy GF; Liu C; Alpdogan O; van den Brink MR J Immunol; 2007 Aug; 179(3):1669-80. PubMed ID: 17641033 [TBL] [Abstract][Full Text] [Related]
28. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. Canaday DH; Wilkinson RJ; Li Q; Harding CV; Silver RF; Boom WH J Immunol; 2001 Sep; 167(5):2734-42. PubMed ID: 11509617 [TBL] [Abstract][Full Text] [Related]
29. CD4+ and CD8+ T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histocompatibility complex-disparate recipients. Blazar BR; Taylor PA; Vallera DA Transplantation; 1997 Aug; 64(4):571-6. PubMed ID: 9293867 [TBL] [Abstract][Full Text] [Related]
30. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Pan L; Teshima T; Hill GR; Bungard D; Brinson YS; Reddy VS; Cooke KR; Ferrara JL Blood; 1999 Jun; 93(12):4071-8. PubMed ID: 10361103 [TBL] [Abstract][Full Text] [Related]
31. T cell TRAIL promotes murine lupus by sustaining effector CD4 Th cell numbers and by inhibiting CD8 CTL activity. Rus V; Nguyen V; Puliaev R; Puliaeva I; Zernetkina V; Luzina I; Papadimitriou JC; Via CS J Immunol; 2007 Mar; 178(6):3962-72. PubMed ID: 17339497 [TBL] [Abstract][Full Text] [Related]
32. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism. Williams NS; Engelhard VH J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456 [TBL] [Abstract][Full Text] [Related]
33. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation. Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477 [TBL] [Abstract][Full Text] [Related]
34. Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis. Capitini CM; Nasholm NM; Duncan BB; Guimond M; Fry TJ J Immunol; 2013 Feb; 190(3):1351-9. PubMed ID: 23275602 [TBL] [Abstract][Full Text] [Related]
35. FK506 inhibits severe graft-versus-host disease without mediating the involvement of perforin and granzyme B. Tao HR Hokkaido Igaku Zasshi; 1998 May; 73(3):227-37. PubMed ID: 9719949 [TBL] [Abstract][Full Text] [Related]
36. Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease. Du W; Leigh ND; Bian G; O'Neill RE; Mei L; Qiu J; Chen GL; Hahn T; Liu H; McCarthy PL; Cao X J Immunol; 2015 Nov; 195(9):4514-23. PubMed ID: 26392464 [TBL] [Abstract][Full Text] [Related]
37. Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function. Baker MB; Riley RL; Podack ER; Levy RB Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1366-71. PubMed ID: 9037059 [TBL] [Abstract][Full Text] [Related]
39. Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells. Williams NS; Engelhard VH J Immunol; 1997 Sep; 159(5):2091-9. PubMed ID: 9278294 [TBL] [Abstract][Full Text] [Related]
40. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. Yasukawa M; Ohminami H; Arai J; Kasahara Y; Ishida Y; Fujita S Blood; 2000 Apr; 95(7):2352-5. PubMed ID: 10733506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]